Cite Filings / TCRT / 9999999997-21-000656

Feed Companies Filings Check

Sign in

SEC STAFF LETTER

SEC Staff Letter Redacted Exhibit

Alaunos Therapeutics, Inc. Filed 2021-03-11 Acc 9999999997-21-000656

Documents 1

SEC STAFF LETTER SEC Staff Letter Redacted Exhibit , filename1.pdf

Around this filing

2021-03-11 SEC STAFF LETTER SEC Staff Letter Redacted Exhibit
2021-03-08 4 EVP, GM Gene Therapy acquired 31,500 shares (grant or award)
2021-03-08 4 Chief Legal Officer and Sec. acquired 43,500 shares (grant or award)
2021-03-08 4 Interim CEO acquired 90,000 shares (grant or award)
2021-03-08 4 EVP, GM Cell Therapy acquired 50,825 shares (grant or award)
2021-02-10 SEC STAFF LETTER SEC Staff Letter Redacted Exhibit

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading filename1.pdf…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…